USA FDA Public consultation on Draft guidance (Catapult’s regulatory round-up – June)
| Title | Consultation period | Category | |
| 1. | Pediatric Drug Development: Regulatory Considerations — Complying With the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Unde r the Best Pharmaceuticals for Children Act Guidance for Industry | End date: 17 July 2023 | Draft guidance |
Published on the 3rd of July 2023. Read the Regulatory Round-up – June 2023 (catapult.org.uk) following this link.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (21 février 2024). USA FDA Public consultation on Draft guidance (Catapult’s regulatory round-up – June). ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/vvnd





